• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Academic Affairs
    • Thomas Harriot College of Arts and Sciences
    • Biology
    • View Item
    •   ScholarShip Home
    • Academic Affairs
    • Thomas Harriot College of Arts and Sciences
    • Biology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Effects of Modified Vaccinia Virus Ankara Expressing Mesothelin and the Poxvirus Immunoregulatory A35R gene in the Treatment of Murine Pancreatic Cancer

    Thumbnail
    View/ Open
    Freistaedter_ecu_0600M_10699.pdf (1.519Mb)

    Show full item record
    Author
    Freistaedter, Andrew G.
    Abstract
    Pancreatic cancer is the fourth leading cause of cancer-related deaths in the United States. Pancreatic tumors over-express the protein mesothelin, and therefore, it is used as a tumor target antigen for vaccine development. Our current research uses an improved Modified Vaccinia Ankara poxvirus that we developed to express mesothelin to the murine immune system to treat pancreatic tumors and create an anti-cancer vaccine. PCR, Flow Cytometry, and Western Blot confirmed virus construction, purity, and protein expression. Our hypothesis was that the A35R[delta] recombinant virus would be more efficient at stimulating the immune system and better protect against tumors caused by the Panc02 pancreatic adenocarcinoma cell line. MVA was found to both kill and replicate in Panc02 cells, showing it is an oncolytic virus. However, multiple schemes of infection/vaccination and boosts were used without any significant protection from tumor challenge in mice. Assays to determine immune response against mesothelin suggested that mice vaccinated with the mesothelin-expressing vaccine virus did not generate a strong immune response to mesothelin as expected, however the mice had robust immunity to the poxvirus. Together these results suggest that native mesothelin may not be a good vaccine target antigen for cancer treatment, possibly because immune cells responding to this self-protein are deleted and/or suppressed during development of the immune system as a protection against autoimmunity. Strategies for improving anti-mesothelin immunity are being explored.
    URI
    http://hdl.handle.net/10342/3969
    Subject
     Microbiology; Immunology; Oncology; A35R; Mesothelin; MVA; Pancreactic cancer; Poxviruses; Vaccines; Biology, Microbiology 
    Date
    2012
    Citation:
    APA:
    Freistaedter, Andrew G.. (January 2012). Effects of Modified Vaccinia Virus Ankara Expressing Mesothelin and the Poxvirus Immunoregulatory A35R gene in the Treatment of Murine Pancreatic Cancer (Master's Thesis, East Carolina University). Retrieved from the Scholarship. (http://hdl.handle.net/10342/3969.)

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Freistaedter, Andrew G.. Effects of Modified Vaccinia Virus Ankara Expressing Mesothelin and the Poxvirus Immunoregulatory A35R gene in the Treatment of Murine Pancreatic Cancer. Master's Thesis. East Carolina University, January 2012. The Scholarship. http://hdl.handle.net/10342/3969. March 04, 2021.
    Chicago:
    Freistaedter, Andrew G., “Effects of Modified Vaccinia Virus Ankara Expressing Mesothelin and the Poxvirus Immunoregulatory A35R gene in the Treatment of Murine Pancreatic Cancer” (Master's Thesis., East Carolina University, January 2012).
    AMA:
    Freistaedter, Andrew G.. Effects of Modified Vaccinia Virus Ankara Expressing Mesothelin and the Poxvirus Immunoregulatory A35R gene in the Treatment of Murine Pancreatic Cancer [Master's Thesis]. Greenville, NC: East Carolina University; January 2012.
    Collections
    • Biology
    • Master's Theses
    Publisher
    East Carolina University

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback